Position in ABBV
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,910,988
+$692,354 QoQ
Shares Held
15,542
+5.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#1,469
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BECKER CAPITAL MANAGEMENT INC holds $223,808,539 across 11 Drug Manufacturers - General names. ABBV ranks #8 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
246,132 | $62,510,144 | |
| 2 | MRK |
Merck & Co., Inc.
|
268,226 | $34,467,041 | |
| 3 | AZN |
Astrazeneca PLC
|
176,512 | $33,470,205 | |
| 4 | AMGN |
Amgen Inc
|
85,085 | $30,810,980 | |
| 5 | LLY |
ELI LILLY & Co
|
24,740 | $29,673,900 | |
| 6 | SNY |
Sanofi
|
346,469 | $14,780,367 | |
| 7 | PFE |
Pfizer Inc
|
469,672 | $11,309,701 | |
| 8 | ABBV |
AbbVie Inc.
This page
|
15,542 | $3,910,988 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,910,988 | 15,542 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $3,218,634 | 14,799 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $3,381,195 | 14,798 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,323,988 | 14,356 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $2,703,555 | 14,565 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $3,064,439 | 14,626 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,710,280 | 15,252 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,067,851 | 15,535 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $2,545,185 | 14,839 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,720,756 | 14,941 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,273,099 | 14,668 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,124,744 | 20,963 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,851,425 | 21,164 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $3,292,584 | 20,660 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $3,087,074 | 19,102 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,591,326 | 19,308 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $2,914,634 | 19,030 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $2,899,499 | 17,886 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $2,427,451 | 17,928 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $1,876,938 | 17,400 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $1,971,650 | 17,504 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $1,874,153 | 17,318 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,847,694 | 17,244 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,482,986 | 16,931 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $1,775,879 | 18,088 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $971,727 | 12,754 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||